Abstract
Desmodium styracifolium (D. styracifolium) has been widely used in traditional Chinese medicine for the treatment of urolithiasis. This work was undertaken to investigate extracts from different polarity fractions of D. styracifolium for possible antilithic effects as well as antioxidant potential to explore the underlying phytochemically active constituents of this plant. The extracts of D. styracifolium were divided into four different polarity fractions by petroleum ether (Fr. PE), chloroform (Fr. CH), ethyl acetate (Fr. EA), and n-butyl alcohol (Fr. NB). The antilithic and antioxidant effects were evaluated and compared in vivo on an animal model of calcium oxalate (CaOx) urolithiasis, which was established by administration of 1 % ethylene glycol along with 2 % ammonium chloride in drinking water for 28 days. A total of 60 male Sprague–Dawley rats were randomly divided into six groups: normal control group, lithogenic group, and four different polarity fractions of D. styracifolium-treated groups. At the end of the study, urine, blood, and kidney tissue samples were all collected for evaluation. Among the four polarity fractions of D. styracifolium extracts, the Fr. PE and Fr. NB treatment significantly reduced the CaOx crystal deposition in kidneys, prevented the renal toxic changes like pH, Cr, and BUN. In addition, Fr. PE and Fr. NB treatment significantly decreased urinary excretion of oxalate along with a increase of citrate excretion. The increased amounts of malondialdehyde and decreased activities of superoxide dismutase, catalase, and glutathione peroxidase were detected in lithogenic group, D. styracifolium extracts treatment prevented the oxidative stress changes especially for the Fr. PE and Fr. NB extracts. In conclusion, our data suggest that the extracts from D. styracifolium possess the antiurolithic activity, possibly mediated through the inhibition of CaOx crystal aggregation as well as the alleviation of oxidative injury in the kidney, and the Fr. PE and Fr. NB extracts are the active fractions of D. styracifolium extract.
Similar content being viewed by others
References
Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA 105(28):9841–9846
Tiselius HG (2003) Epidemiology and medical management of stone disease. BJU Int 91(8):758–767
Moe OW (2006) Kidney stones: pathophysiology and medical management. Lancet 367:333–344
Gürocak S, Küpeli B (2006) Consumption of historical and current phytotherapeutic agents for urolithiasis: a critical review. J Urol 176(2):450–455
Miyaoka R, Monga M (2009) Use of traditional Chinese medicine in the management of urinary stone disease. Int Braz J Urol 35(4):396–405
Butterweck V, Khan SR (2009) Herbal medicines in the management of urolithiasis: alternative or complementary? Planta Med 75(10):1095–1103
Zhao M, Duan JA, Che CT (2007) Isoflavanones and their O-glycosides from Desmodium styracifolium. Phytochemistry 68(10):1471–1479
Gohel MD, Wong SP (2006) Chinese herbal medicines and their efficacy in treating renal stones. Urol Res 34(6):365–372
Rodgers AL, Webber D, Ramsout R, Gohel MD (2014) Herbal preparations affect the kinetic factors of calcium oxalate crystallization in synthetic urine: implications for kidney stone therapy. Urolithiasis 42(3):221–225
Mi J, Duan J, Zhang J, Lu J, Wang H, Wang Z (2012) Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats. Urol Res 40(2):151–161
Xiang ST, Zhou JF, Gan S, Rong XL, Li J, Wang SS (2013) Antiurolithiatic activity of aqueous extract from Desmodium styracifolium (Osb.) Merr. on renal calcium oxalate in rats. Chin J Exp Surg 30(6):1166
Xiang ST, Gan S, Zhou JF et al (2014) Effects of aqueous extract from Desmodium styracifolium (Osb.) Merr. on oxidative stress of renal calcium oxalate rat models. Chin J Urol 35(6):465–468
Cao ZG, Liu JH, Zhou SW et al (2004) The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model. Natl Med J China 84(15):1276–1279
Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22(3):659–661
Evan AP, Worcester EM, Coe FL et al (2015) Mechanisms of human kidney stone formation. Urolithiasis 43(Suppl 1):19–32
Robertson WG, Hughes H (1993) Importance of mild hyperoxaluria in the pathogenesis of urolithiasis-new evidence from studies in the Arabian peninsula. Scanning Microsc 7(1):391–402
Khan SR (1997) Animal models of kidney stone formation: an analysis. World J Urol 15(4):236–243
Khan SR, Glenton PA, Byer KJ (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-l-proline. Kidney Int 70(5):914–923
Joshi S, Saylor BT, Wang W et al (2012) Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional study. PLoS One 7:e47738
Atmani F, Slimani Y, Mimouni M et al (2003) Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats. BJU Int 92(1):137–140
Bashir S, Gilani AH (2011) Antiurolithic effect of berberine is mediated through multiple pathways. Eur J Pharmacol 651(1–3):168–175
Soundararajan P, Mahesh R, Ramesh T et al (2006) Effect of Aerva lanata on calcium oxalate urolithiasis in rats. Indian J Exp Biol 44(12):981–986
The State Pharmacopoeia Commission of P.R. China (2005) In: Pharmacopoeia of the People’s Republic of China, vol. I. Chemical Industry Press, Beijing, PR China, p 30
Khan SR (2013) Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol 189(3):803–811
Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33(5):349–357
Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31(1):3–9
Ashok P, Koti BC, Vishwanathswamy AH (2010) Antiurolithiatic and antioxidant activity of Mimusops elengi on ethylene glycol-induced urolithiasis in rats. Indian J Pharmacol 42(6):380–383
Tsujihata M (2008) Mechanism of calcium oxalate renal stone formation and renal tubular cell injury. Int J Urol 15(2):115–120
Li CY, Deng YL, Sun BH (2009) Taurine protected kidney from oxidative injury through mitochondrial-linked pathway in a rat model of nephrolithiasis. Urol Res 37(4):211–220
Naghii MR, Eskandari E, Mofid M, Jafari M, Asadi MH (2014) Antioxidant therapy prevents ethylene glycol-induced renal calcium oxalate crystal deposition in Wistar rats. Int Urol Nephrol 46(6):1231–1238
Acknowledgments
This study was supported by the grand from Guangdong Provincial Department of Science and Technology (No. 2008B030301363). We thank Zhijian Liao, Zhenchao Yin, Yiming Liu, and Aihua Lin for experimental assistance.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Songtao Xiang and Jianfu Zhou contributed equally to this work.
Rights and permissions
About this article
Cite this article
Xiang, S., Zhou, J., Li, J. et al. Antilithic effects of extracts from different polarity fractions of Desmodium styracifolium on experimentally induced urolithiasis in rats. Urolithiasis 43, 433–439 (2015). https://doi.org/10.1007/s00240-015-0795-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-015-0795-z